• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-1,2,3-三唑-1,4-萘醌衍生物:针对绿脓菌素生物合成的新型抗感染治疗靶点抑制剂的研究进展。

1-1,2,3-triazol-1,4-naphthoquinone Derivatives: Novel Inhibitors Targeting Pyocyanin Biosynthesis for Infection Treatment Advances.

机构信息

Departamento de Química Orgânica, Universidade Federal Fluminense, Instituto de Química, Niterói, RJ, 24020, 150, Brazil.

Programa de pós-graduação em Biotecnologia da Universidade Estadual de Feira de Santana, Feira de Santana, BA, Brazil.

出版信息

Curr Top Med Chem. 2024;24(24):2161-2171. doi: 10.2174/0115680266327024240726111230.

DOI:10.2174/0115680266327024240726111230
PMID:39136508
Abstract

BACKGROUND

This study investigates the potential of eleven 1H-1,2,3-triazol-1,4-naphthoquinone conjugates as virulence factor inhibitors (like Pyocyanin) and their affinity for PhzM, a crucial enzyme for Pyocyanin biosynthesis in infections.

METHODS

A straightforward synthetic pathway enabled the production of these compounds, which were characterized and structurally confirmed through spectroscopic analyses. Evaluation of their impact on PhzM thermal stability identified promising candidates for PhzM binders.

RESULTS

Concentration-response behavior elucidated their binding affinity, revealing them as the first reported micromolar affinity ligands for PhzM. Structure-activity relationship analysis emphasized the role of specific molecular moieties in binding affinity modulation, paving the way for future advanced inhibitors' development.

CONCLUSION

These findings highlight the potential of naphthoquinone-triazole derivatives as leads for novel therapeutics against infections.

摘要

背景

本研究调查了 11 个 1H-1,2,3-三唑-1,4-萘醌化合物作为毒力因子抑制剂(如绿脓菌素)的潜力,以及它们对 PhzM 的亲和力,PhzM 是 感染中绿脓菌素生物合成的关键酶。

方法

通过直接的合成途径生产了这些化合物,通过光谱分析对其进行了表征和结构确证。评估它们对 PhzM 热稳定性的影响,确定了 PhzM 结合物的有前途的候选物。

结果

浓度反应行为阐明了它们的结合亲和力,表明它们是第一个报道的对 PhzM 具有微摩尔亲和力的配体。构效关系分析强调了特定分子片段在结合亲和力调节中的作用,为未来开发更先进的抑制剂铺平了道路。

结论

这些发现强调了萘醌-三唑衍生物作为治疗 感染的新型治疗药物的潜在先导化合物。

相似文献

1
1-1,2,3-triazol-1,4-naphthoquinone Derivatives: Novel Inhibitors Targeting Pyocyanin Biosynthesis for Infection Treatment Advances.1-1,2,3-三唑-1,4-萘醌衍生物:针对绿脓菌素生物合成的新型抗感染治疗靶点抑制剂的研究进展。
Curr Top Med Chem. 2024;24(24):2161-2171. doi: 10.2174/0115680266327024240726111230.
2
A novel scaffold to fight pyocyanin production: early steps to novel antivirulence drugs.一种新型支架对抗绿脓菌素产生:新型抗毒药物的早期步骤。
Future Med Chem. 2020 Aug;12(16):1489-1503. doi: 10.4155/fmc-2019-0351. Epub 2020 Aug 10.
3
Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.降低多重耐药铜绿假单胞菌毒力因子绿脓菌素的产生。
J Infect Chemother. 2013 Feb;19(1):82-8. doi: 10.1007/s10156-012-0457-9. Epub 2012 Aug 3.
4
Transforming microbial pigment into therapeutic revelation: extraction and characterization of pyocyanin from Pseudomonas aeruginosa and its therapeutic potential as an antibacterial and anticancer agent.将微生物色素转化为治疗新发现:从铜绿假单胞菌中提取和鉴定绿脓菌素及其作为抗菌和抗癌剂的治疗潜力。
Microb Cell Fact. 2024 Jun 13;23(1):174. doi: 10.1186/s12934-024-02438-6.
5
Development of potent inhibitors of pyocyanin production in Pseudomonas aeruginosa.铜绿假单胞菌中绿脓菌素产生的强效抑制剂的开发。
J Med Chem. 2015 Feb 12;58(3):1298-306. doi: 10.1021/jm5015082. Epub 2015 Feb 3.
6
Synthesis and Biological Evaluation of Coumarins Derivatives as Potential Inhibitors of the Production of Pseudomonas aeruginosa Virulence Factor Pyocyanin.香豆素衍生物的合成及生物评价及其作为铜绿假单胞菌毒力因子绿脓菌素产生抑制剂的潜力。
Curr Top Med Chem. 2018;18(2):149-156. doi: 10.2174/1568026618666180329122704.
7
Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosa.铜绿假单胞菌中绿脓菌素生物合成蛋白PhzM的结构与功能分析
Biochemistry. 2007 Feb 20;46(7):1821-8. doi: 10.1021/bi6024403. Epub 2007 Jan 25.
8
Overexpression of phzM contributes to much more production of pyocyanin converted from phenazine-1-carboxylic acid in the absence of RpoS in Pseudomonas aeruginosa.在铜绿假单胞菌中,phzM 的过表达导致在没有 RpoS 的情况下,更多地从吩嗪-1-羧酸转化为绿脓菌素。
Arch Microbiol. 2020 Aug;202(6):1507-1515. doi: 10.1007/s00203-020-01837-8. Epub 2020 Mar 28.
9
Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub-inhibitory concentrations of three common antibiotics.在三种常见抗生素的亚抑菌浓度下,环境铜绿假单胞菌分离株产毒能力的变化。
PLoS One. 2021 Mar 4;16(3):e0248014. doi: 10.1371/journal.pone.0248014. eCollection 2021.
10
Inhibition of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics.通过群体感应模拟物抑制野生型细胞中铜绿假单胞菌毒力因子绿脓菌素的产生。
Org Biomol Chem. 2012 Nov 14;10(42):8452-64. doi: 10.1039/c2ob26501j. Epub 2012 Sep 27.

本文引用的文献

1
Protocol for performing and optimizing differential scanning fluorimetry experiments.进行和优化差示扫描荧光法实验的方案。
STAR Protoc. 2023 Dec 15;4(4):102688. doi: 10.1016/j.xpro.2023.102688. Epub 2023 Nov 8.
2
Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.热迁移分析用于小 GTPase 稳定性筛选:评估和适用性。
Int J Mol Sci. 2022 Jun 26;23(13):7095. doi: 10.3390/ijms23137095.
3
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.
铜绿假单胞菌:发病机制、毒力因子、抗生素耐药性、与宿主的相互作用、技术进展和新兴治疗方法。
Signal Transduct Target Ther. 2022 Jun 25;7(1):199. doi: 10.1038/s41392-022-01056-1.
4
Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to PhzS.噻唑烷二酮衍生物的合成及生物评价具有高配体效率对 PhzS。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1217-1229. doi: 10.1080/14756366.2021.1931165.
5
Targeting Bacterial Sortases in Search of Anti-Virulence Therapies with Low Risk of Resistance Development.靶向细菌分选酶以寻找耐药性发展风险低的抗毒力疗法。
Pharmaceuticals (Basel). 2021 Apr 30;14(5):415. doi: 10.3390/ph14050415.
6
A novel scaffold to fight pyocyanin production: early steps to novel antivirulence drugs.一种新型支架对抗绿脓菌素产生:新型抗毒药物的早期步骤。
Future Med Chem. 2020 Aug;12(16):1489-1503. doi: 10.4155/fmc-2019-0351. Epub 2020 Aug 10.
7
Antimicrobial Resistance: Implications and Costs.抗菌药物耐药性:影响与成本
Infect Drug Resist. 2019 Dec 20;12:3903-3910. doi: 10.2147/IDR.S234610. eCollection 2019.
8
An integrated genomic regulatory network of virulence-related transcriptional factors in Pseudomonas aeruginosa.铜绿假单胞菌毒力相关转录因子的综合基因组调控网络。
Nat Commun. 2019 Jul 3;10(1):2931. doi: 10.1038/s41467-019-10778-w.
9
Structure-based Druggability Assessment of Anti-virulence Targets from Pseudomonas aeruginosa.基于结构的铜绿假单胞菌抗毒力靶点药物可开发性评估。
Curr Protein Pept Sci. 2019;20(12):1189-1203. doi: 10.2174/1389203720666190417120758.
10
Case Study: Muscle Atrophy, Hypertrophy, and Energy Expenditure of a Premier League Soccer Player During Rehabilitation From Anterior Cruciate Ligament Injury.案例研究:一名英超足球运动员前交叉韧带损伤康复期间的肌肉萎缩、肥大与能量消耗
Int J Sport Nutr Exerc Metab. 2019 Sep 1;29(5):559-566. doi: 10.1123/ijsnem.2018-0391.